Table 1.
Reagent ID | Formulation Dilution Factor | Expected IgG concentration (IU or AU/mL) |
||||
---|---|---|---|---|---|---|
Act | Fha | Fim2/3 | Prn | Pt | ||
| ||||||
2012812612a | Neat | 129.92 | 113.58 | 1153.47 | 1299.40 | 171.28 |
MCR0001 | 2 | 64.96 | 56.79 | 576.74 | 649.70 | 85.64 |
MCR0002 | 4 | 32.48 | 28.40 | 288.37 | 324.85 | 42.82 |
MCR0003 | 16 | 8.12 | 7.10 | 72.09 | 81.21 | 10.71 |
MCR0004 | 30 | 4.33 | 3.79 | 38.45 | 43.31 | 5.71 |
MCR0005 | 120 | 1.08 | 0.95 | 9.61 | 10.83 | 1.43 |
MCR0006 | 500 | 0.26 | 0.23 | 2.31 | 2.60 | 0.34 |
MCR0007 | 2000 | 0.06 | 0.06 | 0.58 | 0.65 | 0.09 |
| ||||||
2012789123a | Neat | 264.62 | 1015.55 | 320.60 | 1771.89 | 45.86 |
MCR0008 | 2 | 132.31 | 507.78 | 160.30 | 885.95 | 22.93 |
MCR0009 | 4 | 66.16 | 253.89 | 80.15 | 442.97 | 11.47 |
MCR0010 | 16 | 16.54 | 63.47 | 20.04 | 110.74 | 2.87 |
MCR0011 | 30 | 8.82 | 33.85 | 10.69 | 59.06 | 1.53 |
MCR0012 | 120 | 2.21 | 8.46 | 2.67 | 14.77 | 0.38 |
MCR0013 | 500 | 0.53 | 2.03 | 0.64 | 3.54 | 0.09 |
MCR0014 | 2000 | 0.13 | 0.51 | 0.16 | 0.89 | 0.02 |
| ||||||
WHO06/142a | Neat | 64.65 | 107.11 | 38.51 | 29.50 | 82.88 |
MCR0015 | 2 | 32.33 | 53.56 | 19.26 | 14.75 | 41.44 |
MCR0016 | 4 | 16.16 | 26.78 | 9.63 | 7.38 | 20.72 |
MCR0017 | 6 | 10.78 | 17.85 | 6.42 | 4.92 | 13.81 |
MCR0018 | 12 | 5.39 | 8.93 | 3.21 | 2.46 | 6.91 |
MCR0019 | 50 | 1.29 | 2.14 | 0.77 | 0.59 | 1.66 |
MCR0020 | 200 | 0.32 | 0.54 | 0.19 | 0.15 | 0.41 |
MCR0021 | 750 | 0.09 | 0.14 | 0.05 | 0.04 | 0.11 |
Act – Adenylate cyclase; Fha – filamentous hemagglutinin; Fim2/3 - Fimbria; Prn – Pertactin; Pt – Pertussis toxin antigens.
Human sera spiked into human serum depleted of total IgG, IgA and IgM (MCR0028) to formulate a serum panel (MCR0001 – MCR0021) for MMACA assay development and characterization.